The Department of Healthcare and Family Services (HFS) will post its updated Preferred Drug List (PDL) on March 13. This update will include all changes that have been made during the past 12 months. While the Pharmacy Benefit Management System (PBMS) prior authorization system is pending restoration. HFS’ PDL is available online.
Also, the Department of Healthcare and Family Services’ (HFS) new Preferred Drug List (PDL) will be posted March 13. Starting immediately, HFS has changed the covered preferred blood glucose monitoring and testing supplies. The preferred products for all fee-for-service (FFS) and managed care organization (MCO) members are the Ascensia items below:
- NDC 00193758450 Item: Contour Plus Blood Glucose Test Strips and
- NDC 00193703601 Item: Contour Plus Blue Blood Glucose Monitoring System.
These products will be updated accordingly on the PDL on March 13. Providers should check with the respective MCOs for details on their transition timelines.
For additional information, please contact a pharmacy billing representative in the Bureau of Professional and Ancillary Services at 877-782-5565, or the applicable MCO.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.